Epigenomic Reprogramming in Gout

Gout is a crystal-induced arthropathy in which monosodium urate (MSU) crystals precipitate within joints as a result of persistent hyperuricemia and elicit an inflammatory response. An intriguing aspect is the occurrence of gout in only 10–15% of hyperuricemic individuals, suggesting the presence of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gout, Urate, and Crystal Deposition Disease Urate, and Crystal Deposition Disease, 2024-11, Vol.2 (4), p.325-338
Hauptverfasser: Straton, Ancuta R., Kischkel, Brenda, Crișan, Tania O., Joosten, Leo A. B.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 338
container_issue 4
container_start_page 325
container_title Gout, Urate, and Crystal Deposition Disease
container_volume 2
creator Straton, Ancuta R.
Kischkel, Brenda
Crișan, Tania O.
Joosten, Leo A. B.
description Gout is a crystal-induced arthropathy in which monosodium urate (MSU) crystals precipitate within joints as a result of persistent hyperuricemia and elicit an inflammatory response. An intriguing aspect is the occurrence of gout in only 10–15% of hyperuricemic individuals, suggesting the presence of additional risk factors. Although MSU crystal deposition is widely recognized as the cause of gout flares, the variability in initiating the inflammatory response to hyperuricemia and MSU deposition is not well understood. Several studies bring up-to-date information about the environmental and genetic influences on the progression towards clinical gout. Elevated urate concentrations and exposure to different external factors precipitate gout flares, highlighting the potential involvement of epigenetic mechanisms in gouty inflammation. A better understanding of the alteration of the epigenetic landscape in gout may provide new perspectives on the dysregulated inflammatory response. In this review, we focus on understanding the current view of the role of epigenomic reprogramming in gout and the mechanistic pathways of action.
doi_str_mv 10.3390/gucdd2040023
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_3390_gucdd2040023</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3390_gucdd2040023</sourcerecordid><originalsourceid>FETCH-LOGICAL-c753-77278913218d3d7a12fd1fd3d5f7ce6170c0b0c81b9b50b21e90b73efc5432813</originalsourceid><addsrcrecordid>eNpNj8tqAkEQRZugEDHu_ID5gEys6pq2epZBjAkIgeB-mH4NDZkH3XHh3xtJFq7uWV3OEWKN8EJUw6Y7W-ckVACSHsRCaqSyUppmd_woVjlHA0oRb7XSC1Hsp9j5YeyjLb78lMYutX0fh66IQ3EYzz9PYh7a7-xX_7sUp7f9afdeHj8PH7vXY2lZUcksWddIErUjxy3K4DD8ogps_RYZLBiwGk1tFBiJvgbD5INVFd30luL579amMefkQzOl2Lfp0iA0t77mvo-uJRBCAw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Epigenomic Reprogramming in Gout</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><creator>Straton, Ancuta R. ; Kischkel, Brenda ; Crișan, Tania O. ; Joosten, Leo A. B.</creator><creatorcontrib>Straton, Ancuta R. ; Kischkel, Brenda ; Crișan, Tania O. ; Joosten, Leo A. B.</creatorcontrib><description>Gout is a crystal-induced arthropathy in which monosodium urate (MSU) crystals precipitate within joints as a result of persistent hyperuricemia and elicit an inflammatory response. An intriguing aspect is the occurrence of gout in only 10–15% of hyperuricemic individuals, suggesting the presence of additional risk factors. Although MSU crystal deposition is widely recognized as the cause of gout flares, the variability in initiating the inflammatory response to hyperuricemia and MSU deposition is not well understood. Several studies bring up-to-date information about the environmental and genetic influences on the progression towards clinical gout. Elevated urate concentrations and exposure to different external factors precipitate gout flares, highlighting the potential involvement of epigenetic mechanisms in gouty inflammation. A better understanding of the alteration of the epigenetic landscape in gout may provide new perspectives on the dysregulated inflammatory response. In this review, we focus on understanding the current view of the role of epigenomic reprogramming in gout and the mechanistic pathways of action.</description><identifier>ISSN: 2813-4583</identifier><identifier>EISSN: 2813-4583</identifier><identifier>DOI: 10.3390/gucdd2040023</identifier><language>eng</language><ispartof>Gout, Urate, and Crystal Deposition Disease, 2024-11, Vol.2 (4), p.325-338</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c753-77278913218d3d7a12fd1fd3d5f7ce6170c0b0c81b9b50b21e90b73efc5432813</cites><orcidid>0000-0001-6166-9830 ; 0009-0005-3148-2078</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Straton, Ancuta R.</creatorcontrib><creatorcontrib>Kischkel, Brenda</creatorcontrib><creatorcontrib>Crișan, Tania O.</creatorcontrib><creatorcontrib>Joosten, Leo A. B.</creatorcontrib><title>Epigenomic Reprogramming in Gout</title><title>Gout, Urate, and Crystal Deposition Disease</title><description>Gout is a crystal-induced arthropathy in which monosodium urate (MSU) crystals precipitate within joints as a result of persistent hyperuricemia and elicit an inflammatory response. An intriguing aspect is the occurrence of gout in only 10–15% of hyperuricemic individuals, suggesting the presence of additional risk factors. Although MSU crystal deposition is widely recognized as the cause of gout flares, the variability in initiating the inflammatory response to hyperuricemia and MSU deposition is not well understood. Several studies bring up-to-date information about the environmental and genetic influences on the progression towards clinical gout. Elevated urate concentrations and exposure to different external factors precipitate gout flares, highlighting the potential involvement of epigenetic mechanisms in gouty inflammation. A better understanding of the alteration of the epigenetic landscape in gout may provide new perspectives on the dysregulated inflammatory response. In this review, we focus on understanding the current view of the role of epigenomic reprogramming in gout and the mechanistic pathways of action.</description><issn>2813-4583</issn><issn>2813-4583</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNj8tqAkEQRZugEDHu_ID5gEys6pq2epZBjAkIgeB-mH4NDZkH3XHh3xtJFq7uWV3OEWKN8EJUw6Y7W-ckVACSHsRCaqSyUppmd_woVjlHA0oRb7XSC1Hsp9j5YeyjLb78lMYutX0fh66IQ3EYzz9PYh7a7-xX_7sUp7f9afdeHj8PH7vXY2lZUcksWddIErUjxy3K4DD8ogps_RYZLBiwGk1tFBiJvgbD5INVFd30luL579amMefkQzOl2Lfp0iA0t77mvo-uJRBCAw</recordid><startdate>20241101</startdate><enddate>20241101</enddate><creator>Straton, Ancuta R.</creator><creator>Kischkel, Brenda</creator><creator>Crișan, Tania O.</creator><creator>Joosten, Leo A. B.</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0001-6166-9830</orcidid><orcidid>https://orcid.org/0009-0005-3148-2078</orcidid></search><sort><creationdate>20241101</creationdate><title>Epigenomic Reprogramming in Gout</title><author>Straton, Ancuta R. ; Kischkel, Brenda ; Crișan, Tania O. ; Joosten, Leo A. B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c753-77278913218d3d7a12fd1fd3d5f7ce6170c0b0c81b9b50b21e90b73efc5432813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Straton, Ancuta R.</creatorcontrib><creatorcontrib>Kischkel, Brenda</creatorcontrib><creatorcontrib>Crișan, Tania O.</creatorcontrib><creatorcontrib>Joosten, Leo A. B.</creatorcontrib><collection>CrossRef</collection><jtitle>Gout, Urate, and Crystal Deposition Disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Straton, Ancuta R.</au><au>Kischkel, Brenda</au><au>Crișan, Tania O.</au><au>Joosten, Leo A. B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epigenomic Reprogramming in Gout</atitle><jtitle>Gout, Urate, and Crystal Deposition Disease</jtitle><date>2024-11-01</date><risdate>2024</risdate><volume>2</volume><issue>4</issue><spage>325</spage><epage>338</epage><pages>325-338</pages><issn>2813-4583</issn><eissn>2813-4583</eissn><abstract>Gout is a crystal-induced arthropathy in which monosodium urate (MSU) crystals precipitate within joints as a result of persistent hyperuricemia and elicit an inflammatory response. An intriguing aspect is the occurrence of gout in only 10–15% of hyperuricemic individuals, suggesting the presence of additional risk factors. Although MSU crystal deposition is widely recognized as the cause of gout flares, the variability in initiating the inflammatory response to hyperuricemia and MSU deposition is not well understood. Several studies bring up-to-date information about the environmental and genetic influences on the progression towards clinical gout. Elevated urate concentrations and exposure to different external factors precipitate gout flares, highlighting the potential involvement of epigenetic mechanisms in gouty inflammation. A better understanding of the alteration of the epigenetic landscape in gout may provide new perspectives on the dysregulated inflammatory response. In this review, we focus on understanding the current view of the role of epigenomic reprogramming in gout and the mechanistic pathways of action.</abstract><doi>10.3390/gucdd2040023</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0001-6166-9830</orcidid><orcidid>https://orcid.org/0009-0005-3148-2078</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2813-4583
ispartof Gout, Urate, and Crystal Deposition Disease, 2024-11, Vol.2 (4), p.325-338
issn 2813-4583
2813-4583
language eng
recordid cdi_crossref_primary_10_3390_gucdd2040023
source MDPI - Multidisciplinary Digital Publishing Institute
title Epigenomic Reprogramming in Gout
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A42%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epigenomic%20Reprogramming%20in%20Gout&rft.jtitle=Gout,%20Urate,%20and%20Crystal%20Deposition%20Disease&rft.au=Straton,%20Ancuta%20R.&rft.date=2024-11-01&rft.volume=2&rft.issue=4&rft.spage=325&rft.epage=338&rft.pages=325-338&rft.issn=2813-4583&rft.eissn=2813-4583&rft_id=info:doi/10.3390/gucdd2040023&rft_dat=%3Ccrossref%3E10_3390_gucdd2040023%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true